Historique
Article de Périodique
A cost-benefit analysis of a potential supervised injection facility in San Francisco, California, USA (2017)
Auteur(s) :
IRWIN, A. ;
JOZAGHI, E. ;
BLUTHENTHAL, R. N. ;
KRAL, A. H.
Année
2017
Page(s) :
164-184
Langue(s) :
Anglais
Domaine :
Drogues illicites / Illicit drugs
Discipline :
SAN (Santé publique / Public health)
Thésaurus géographique
ETATS-UNIS
;
CANADA
Thésaurus mots-clés
REDUCTION DES RISQUES ET DES DOMMAGES
;
SALLE DE CONSOMMATION A MOINDRE RISQUE
;
COUT
;
BENEFICE
;
EVALUATION
;
ECONOMIE
;
INFECTION
;
VIH
;
HEPATITE
;
MODELE
;
SURDOSE
Note générale :
Voir aussi :
McCarthy M. Supervised injection centers could save millions of dollars in health costs, US study finds. British Medical Journal, 2016; 355: i6762
McCarthy M. Supervised injection centers could save millions of dollars in health costs, US study finds. British Medical Journal, 2016; 355: i6762
Résumé :
Supervised injection facilities (SIFs) have been shown to reduce infection, prevent overdose deaths, and increase treatment uptake. The United States is in the midst of an opioid epidemic, yet no sanctioned SIF currently operates in the United States. We estimate the economic costs and benefits of establishing a potential SIF in San Francisco using mathematical models that combine local public health data with previous research on the effects of existing SIFs. We consider potential savings from five outcomes: averted HIV and hepatitis C virus (HCV) infections, reduced skin and soft tissue infection (SSTI), averted overdose deaths, and increased medication-assisted treatment (MAT) uptake. We find that each dollar spent on a SIF would generate US$2.33 in savings, for total annual net savings of US$3.5 million for a single 13-booth SIF. Our analysis suggests that a SIF in San Francisco would not only be a cost-effective intervention but also a significant boost to the public health system.
Affiliation :
Criminal Justice Policy Foundation, Silver Spring, MD, USA
Cote :
Abonnement